• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    7/24/23 3:48:22 PM ET
    $ADCT
    $ADTX
    $AIRG
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADCT alert in real time by email

     

    On Monday morning, 70 companies achieved new lows for the year.

    Interesting Facts About Today's 52-Week Lows:

    • Estee Lauder Cos (NYSE:EL) was the largest firm by market cap to set a new 52-week low.
    • 9 Meters Biopharma (NASDAQ:NMTR) was the smallest firm on a market cap basis to set a new 52-week low.
    • AppHarvest (NASDAQ:APPH) was the biggest loser, trading down 70.3% to reach its 52-week low.
    • SWK Holdings (NASDAQ:SWKH) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

    Over the course of the first half-hour of trading on Monday, the following stocks hit new 52-week lows:

    • Estee Lauder Cos (NYSE:EL) stock broke to a new 52-week low of $171.94 on Monday. Shares of the company traded down 2.62%.
    • NovoCure (NASDAQ:NVCR) stock broke to a new 52-week low of $37.92 on Monday. Shares of the company traded down 2.0%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock drifted down 2.66% on Monday morning to hit a new 52-week low of $32.75.
    • Cytokinetics (NASDAQ:CYTK) shares were down 0.95% for the day, having made a 52-week low of $32.05.
    • Nu Skin Enterprises (NYSE:NUS) shares moved down 0.12% on Monday to hit a new 52-week low of $28.18, drifting down 0.12%.
    • Lifezone Metals (NYSE:LZM) stock achieved a new 52-week low on Monday morning, hitting $9.03 and moving down 11.94%.
    • Avidity Biosciences (NASDAQ:RNA) stock drifted down 2.74% on Monday morning to hit a new 52-week low of $9.71.
    • Beneficient (NASDAQ:BENF) stock drifted down 3.24% on Monday morning to hit a new 52-week low of $2.03.
    • uniQure (NASDAQ:QURE) stock achieved a new 52-week low on Monday morning, hitting $9.72 and moving down 1.75%.
    • AnaptysBio (NASDAQ:ANAB) shares hit a yearly low of $17.51. The stock was down 2.57% on the session.
    • Enanta Pharma (NASDAQ:ENTA) shares moved down 2.87% on Monday to hit a new 52-week low of $18.17, drifting down 2.87%.
    • Compute Health (NYSE:CPUH) stock hit $9.70 on Monday morning, setting a new 52-week low for a change of down 0.28%.
    • BRC (NYSE:BRCC) shares made a new 52-week low of $4.76 on Monday. The stock was down 2.44% for the day.
    • SWK Holdings (NASDAQ:SWKH) stock hit a new 52-week low of $16.10. The stock was 0.0% (flat) on the session.
    • FibroGen (NASDAQ:FGEN) shares fell to $1.98 on Monday, setting a new 52-week low with a shift of down 3.88%.
    • Inogen (NASDAQ:INGN) shares set a new 52-week low of $8.32. The stock traded down 2.43%.
    • Kodiak Sciences (NASDAQ:KOD) shares made a new 52-week low of $2.77 on Monday. The stock was down 50.48% for the day.
    • Altimmune (NASDAQ:ALT) stock hit a yearly low of $3.04. The stock was down 1.95% for the day.
    • ADC Therapeutics (NYSE:ADCT) shares were down 3.87% for the day, having made a 52-week low of $1.35.
    • Carmell Therapeutics (NASDAQ:CTCX) stock dropped to a yearly low on Monday of $4.60. Shares traded down 11.03%.
    • CEL-SCI (AMEX:CVM) stock achieved a new 52-week low on Monday morning, hitting $1.78 and moving down 8.88%.
    • Durect (NASDAQ:DRRX) stock dropped to a yearly low on Monday of $2.96. Shares traded up 0.98%.
    • Theratechnologies (NASDAQ:THTX) shares made a new 52-week low of $0.58 on Monday. The stock was down 11.97% for the day.
    • Airgain (NASDAQ:AIRG) shares set a new 52-week low of $4.76. The stock traded up 0.41%.
    • Westwater Resources (AMEX:WWR) stock dropped to a yearly low on Monday of $0.77. Shares traded up 2.81%.
    • Nautilus (NYSE:NLS) shares moved up 1.42% on Monday to hit a new 52-week low of $1.04, drifting up 1.42%.
    • Interactive Strength (NASDAQ:TRNR) shares moved down 7.57% on Monday to hit a new 52-week low of $2.00, drifting down 7.57%.
    • Purple Biotech (NASDAQ:PPBT) stock achieved a new 52-week low on Monday morning, hitting $1.18 and moving down 1.64%.
    • BioCardia (NASDAQ:BCDA) stock hit a new 52-week low of $1.01. The stock was down 46.97% on the session.
    • Zivo Bioscience (NASDAQ:ZIVO) shares moved up 1.61% on Monday to hit a new 52-week low of $1.76, drifting up 1.61%.
    • WANG & LEE Group (NASDAQ:WLGS) stock hit $1.11 on Monday morning, setting a new 52-week low for a change of down 1.74%.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $3.83. The stock was down 5.69% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a new 52-week low of $0.25. The stock was down 6.54% on the session.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock dropped to a yearly low on Monday of $1.04. Shares traded down 12.34%.
    • Greenbrook TMS (NASDAQ:GBNH) stock broke to a new 52-week low of $0.31 on Monday. Shares of the company traded down 9.81%.
    • 60 Degrees (NASDAQ:SXTP) shares reached a new 52-week low of $2.31 on Monday morning, moving down 11.61%.
    • Golden Minerals (AMEX:AUMN) stock achieved a new 52-week low on Monday morning, hitting $1.33 and moving down 2.84%.
    • GRI Bio (NASDAQ:GRI) shares set a new yearly low of $3.53 this morning. The stock was down 0.84% on the session.
    • Powerbridge Technologies (NASDAQ:PBTS) stock drifted down 4.75% on Monday morning to hit a new 52-week low of $0.30.
    • Bio-Path Hldgs (NASDAQ:BPTH) shares hit a yearly low of $1.17. The stock was down 2.5% on the session.
    • Taoping (NASDAQ:TAOP) shares set a new 52-week low of $0.47. The stock traded down 2.02%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $0.04 on Monday morning, moving down 5.47%.
    • Titan Pharma (NASDAQ:TTNP) stock dropped to a yearly low on Monday of $0.51. Shares traded down 1.12%.
    • Micromobility com (NASDAQ:MCOM) shares fell to $0.08 on Monday, setting a new 52-week low with a shift of down 4.92%.
    • ViewRay (NASDAQ:VRAY) shares set a new 52-week low of $0.04. The stock traded down 31.69%.
    • FOXO Technologies (AMEX:FOXO) shares set a new 52-week low of $0.13. The stock traded down 3.13%.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) shares set a new yearly low of $4.03 this morning. The stock was down 4.05% on the session.
    • iSun (NASDAQ:ISUN) stock dropped to a yearly low on Monday of $0.33. Shares traded down 6.59%.
    • Shineco (NASDAQ:SISI) shares reached a new 52-week low of $0.22 on Monday morning, moving down 7.5%.
    • C3is (NASDAQ:CISS) shares fell to $0.70 on Monday, setting a new 52-week low with a shift of down 4.48%.
    • SuperCom (NASDAQ:SPCB) stock drifted down 3.72% on Monday morning to hit a new 52-week low of $0.78.
    • Ra Medical Systems (AMEX:RMED) shares hit a yearly low of $0.61. The stock was up 1.03% on the session.
    • ZyVersa Therapeutics (NASDAQ:ZVSA) shares reached a new 52-week low of $0.16 on Monday morning, moving down 12.55%.
    • Salarius Pharmaceuticals (NASDAQ:SLRX) stock hit a new 52-week low of $1.00. The stock was down 1.43% on the session.
    • Avalo Therapeutics (NASDAQ:AVTX) shares were down 13.87% for the day, having made a 52-week low of $0.25.
    • Grom Social Enterprises (NASDAQ:GROM) shares hit a yearly low of $0.29. The stock was down 11.11% on the session.
    • Aditxt (NASDAQ:ADTX) shares were down 1.84% for the day, having made a 52-week low of $0.40.
    • E-Home Household Service (NASDAQ:EJH) stock hit a new 52-week low of $0.10. The stock was down 11.83% on the session.
    • Esports Entertainment (NASDAQ:GMBL) shares reached a new 52-week low of $0.56 on Monday morning, moving down 2.38%.
    • BitNile Metaverse (NASDAQ:BNMV) shares hit a yearly low of $0.93. The stock was down 8.1% on the session.
    • Sigma Additive Solutions (NASDAQ:SASI) stock hit a yearly low of $0.19. The stock was down 12.17% for the day.
    • 9 Meters Biopharma (NASDAQ:NMTR) stock dropped to a yearly low on Monday of $0.12. Shares traded down 13.01%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ADTX
    $AIRG
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    uniQure N.V.
    $QURE
    1/28/2026$31.00Equal Weight
    Barclays
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Airgain Inc.
    $AIRG
    1/21/2026$6.00Buy
    Lake Street
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Estee Lauder upgraded by Citigroup with a new price target

    Citigroup upgraded Estee Lauder from Neutral to Buy and set a new price target of $120.00

    2/6/26 8:05:27 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on uniQure with a new price target

    Barclays initiated coverage of uniQure with a rating of Equal Weight and set a new price target of $31.00

    1/28/26 7:20:10 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    SEC Filings

    View All

    FOXO Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    2/6/26 5:05:52 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form S-8 filed by Altimmune Inc.

    S-8 - Altimmune, Inc. (0001326190) (Filer)

    2/6/26 4:07:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Addentax Group Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ADDENTAX GROUP CORP. (0001650101) (Filer)

    2/6/26 9:15:29 AM ET
    $ATXG
    Professional Services
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Cornell Alison A bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 4% to 279,481 units (SEC Form 4)

    4 - Zivo Bioscience, Inc. (0001101026) (Issuer)

    1/28/26 4:11:45 PM ET
    $ZIVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Payne John Bernard bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 148% to 19,618 units (SEC Form 4)

    4 - Zivo Bioscience, Inc. (0001101026) (Issuer)

    1/28/26 4:06:16 PM ET
    $ZIVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness

    The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity Nu Skin Enterprises Inc. (NYSE:NUS) today announced the relaunch of "The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young," the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin's Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin's science-led innovations — from ageLOC® technology to the company's intelligent beauty and wellne

    2/6/26 1:56:00 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care

    Addentax Group Corp. Announces Proposed Acquisition of Artificial Intelligence (AI)-empowered and Crypto-enabled Asset Management Platform, with Potential to Generate Approximately HKD 300 Million in Revenue

    SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- Addentax Group Corp. (NASDAQ:ATXG) (the "Company", "ATXG", "we", "us" or "our") today announced the proposed strategic acquisition of the offshore wealth management and integrated cross-border service business of Hong Kong-based Riches Group, a provider of global asset allocation and cross-border services. The Company believes that, if completed, the proposed acquisition would support the Company's global expansion strategy by facilitating the integration of Riches Group's offshore business ecosystem, AI-enabled financial solutions, and digital currency/crypto service offerings. Based on preliminary internal estimates and subject to final closing

    2/6/26 9:20:00 AM ET
    $ATXG
    Professional Services
    Consumer Discretionary

    The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

    FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen training for domestic service personnel, improve service quality, and introduce AI technology. The company will progressively roll out a human-machine integrated service model and make effective use of tax benefits to increase staff deployment rates, propelling its performance to new heights by 2026. Key support directions for China's 2026 tax policies targeting the domestic service industry: 1. Domestic

    2/6/26 8:30:00 AM ET
    $EJH
    Other Consumer Services
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Commercial Officer Callos Andrew exercised 15,000 shares at a strike of $23.26 and sold $928,950 worth of shares (15,000 units at $61.93) (SEC Form 4)

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    2/5/26 8:17:30 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Francois Cedric exercised 8,840 shares at a strike of $3.76, increasing direct ownership by 2% to 490,837 units (SEC Form 4)

    4 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

    2/5/26 4:14:07 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Toscanini Arthur M. was granted 7,257 shares, increasing direct ownership by 7% to 112,992 units (SEC Form 4)

    4 - AIRGAIN INC (0001272842) (Issuer)

    2/4/26 6:27:05 PM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Financials

    Live finance-specific insights

    View All

    Airgain Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, February 26, at 5:00 p.m. ET

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, will hold a conference call on Thursday, February 26, 2026, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Airgain management will host the presentation, followed by a question-and-answer period. Date: Thursday, February 26, 2026 Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time) Participant Dial-In: 877-407-2988 / +1 201-389-0923 or Call Me Event Confirmation #: 13757859 The conference call will be broadcast simultaneously and available for replay via the investor section of the company's website

    2/5/26 8:00:00 AM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    The Estée Lauder Companies Reports Fiscal 2026 Second Quarter Results

    Delivered Strong Fiscal 2026 Second Quarter and First Half Results across Sales, Margins and EPS Raising Fiscal 2026 Full-Year Outlook The Estée Lauder Companies Inc. (NYSE:EL) today reported its financial results for the second quarter ended December 31, 2025. "We delivered excellent second quarter results to solidify a strong first half of fiscal 2026," said Stéphane de La Faverie, President and CEO. "In this pivotal year, Beauty Reimagined has invigorated our business as we execute the biggest operational, leadership, and cultural transformation in our history. On its one-year anniversary, we raise our fiscal 2026 outlook confident in the strength of our turnaround, even as our sec

    2/5/26 6:00:00 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    The Estée Lauder Companies to Webcast Discussion of Fiscal 2026 Second Quarter Results on February 5, 2026

    The Estée Lauder Companies Inc. (NYSE:EL) will release its fiscal 2026 second quarter results on Thursday, February 5, 2026. On that date, at 8:30 a.m. (ET), the Company will provide a live webcast of its conference call and presentation discussing the results, future prospects and recent corporate developments. Stéphane de La Faverie, President and CEO, and Akhil Shrivastava, EVP and CFO, will host the call. Those wishing to access the webcast can visit http://www.elcompanies.com/investors. The call will be archived on the Company's website. The Estée Lauder Companies Inc. is one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and

    1/29/26 4:45:00 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ADCT
    $ADTX
    $AIRG
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:28 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary